Thank you for requesting the article "Is Diagnostics The New Biotech…And Will Pharma Embrace It?". Please fill out the form below to immediately enjoy your complimentary article. IN VIVO is the premier strategic business resource for medical technology, diagnostics, and biopharma professionals.
Each issue of IN VIVO delivers revealing, in-depth coverage of your competitors' strategies; incisive projections of future industry trends and their implications for your business; expert analysis of key industry developments; exclusive interviews with top industry executives and analysts; and in-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark.
|